Enzo Biochem Valuation
| ENZ Stock | USD 0.61 0.01 1.67% |
Enzo Biochem is fairly valued. Enzo Biochem shows a prevailing Real Value of $0.61 per share. The current price of the firm is $0.61. Our model computes the value of Enzo Biochem from reviewing the firm fundamentals such as Shares Outstanding of 52.24 M, current valuation of (12.81 M), and Profit Margin of (0.82) % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Enzo Biochem's valuation include:
Price Book 0.6642 | Enterprise Value | Enterprise Value Ebitda (3.27) | Price Sales 0.9921 | Enterprise Value Revenue 0.2629 |
Fairly Valued
Today
Please note that Enzo Biochem's price fluctuation is abnormally volatile at this time. Calculation of the real value of Enzo Biochem is based on 3 months time horizon. Increasing Enzo Biochem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Enzo Biochem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enzo Stock. However, Enzo Biochem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.61 | Real 0.61 | Target 5.5 | Hype 0.61 | Naive 0.53 |
The intrinsic value of Enzo Biochem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Enzo Biochem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Enzo Biochem helps investors to forecast how Enzo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enzo Biochem more accurately as focusing exclusively on Enzo Biochem's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Enzo Biochem's intrinsic value based on its ongoing forecasts of Enzo Biochem's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Enzo Biochem's closest peers.
Enzo Biochem Cash |
|
Enzo Valuation Trend
Analysing the historical paterns of Enzo Biochem's enterprise value and its market capitalization is a good way to estimate and gauge the value of Enzo Biochem over time and is usually enough for investors to make rational market timing decisions.
Enzo Biochem Total Value Analysis
Enzo Biochem is currently estimated to have company total value of (12.81 M) with market capitalization of 31.65 M, debt of 3.51 M, and cash on hands of 82.37 M. The negative valuation of Enzo Biochem may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Enzo Biochem fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(12.81 M) | 31.65 M | 3.51 M | 82.37 M |
Enzo Biochem Investor Information
About 22.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enzo Biochem recorded a loss per share of 0.15. The entity last dividend was issued on the 15th of November 2024. The firm had 105:100 split on the 21st of October 2004. Enzo Biochem is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Enzo Biochem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Enzo Biochem has an asset utilization ratio of 37.2 percent. This suggests that the Company is making $0.37 for each dollar of assets. An increasing asset utilization means that Enzo Biochem is more efficient with each dollar of assets it utilizes for everyday operations.Enzo Biochem Ownership Allocation
Enzo Biochem holds a total of 52.24 Million outstanding shares. Enzo Biochem retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Enzo Biochem Profitability Analysis
The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 14.63 M.Enzo Biochem Past Distributions to stockholders
About Enzo Biochem Valuation
Our relative valuation model uses a comparative analysis of Enzo Biochem. We calculate exposure to Enzo Biochem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Enzo Biochem's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 16.8 M | 31.5 M | |
| Pretax Profit Margin | (0.35) | (0.34) | |
| Operating Profit Margin | (0.35) | (0.34) | |
| Net Loss | (0.94) | (0.89) | |
| Gross Profit Margin | 0.53 | 0.61 |
A single share of Enzo Biochem represents a small ownership stake in the entity. As a stockholder of Enzo, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Enzo Biochem Dividends Analysis For Valuation
Please note that Enzo Biochem has scaled down on payment of dividends at this time. Retained Earnings is likely to rise to about (251.7 M) in 2025. Retained Earnings Total Equity is likely to drop to about (272.8 M) in 2025
There are various types of dividends Enzo Biochem can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Enzo shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Enzo Biochem directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Enzo pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Enzo Biochem by the value of the dividends paid out.
Enzo Biochem Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 50.9 M |
Enzo Biochem Current Valuation Indicators
Valuation refers to the process of determining the present value of Enzo Biochem and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Enzo we look at many different elements of the entity such as Enzo's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Enzo Biochem, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Enzo Biochem's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Enzo Biochem's worth.Additional Tools for Enzo Stock Analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.